The European Commission’s Communication on a new EU Action Plan on Antimicrobial Resistance has been released on 29 June. EPHA welcomes the Commission’s effort to go beyond the previous Action Plan (2011-2016) by adopting a clearer “One...
On 19-20 May 2017, the G20 Health Ministers met for the first time, confirming AMR as a major threat to public health and underlining the urgent need for transnational cooperation following the WHO Global Action Plan and the 2016 UN Political Declaration on AMR. The...
Dear Commissioner Bienkowska, We write with regard to the recently published roadmap on a Strategic Approach to Pharmaceuticals in the Environment and the forthcoming Antimicrobial Resistance (AMR) Action Plan. We would like to underline the importance of introducing...
Since the last EU Action Plan on Antimicrobial Resistance (AMR) expired at the end of 2016, the EU now has the opportunity to increase efforts further and ensure that the follow-up Action Plan, to be released in June 2017, builds upon existing strategies to more...
By Sascha Marschang, Director of Operations and Membership ‘Nightmare’ pathogens, able to resist every type of antibiotic on today’s market, are no longer a hypothetical threat. Drug-resistant strains of deadly bacteria are on the rise across the globe. If left...